Durations of Staphylococcus aureus bacteremia according to different phenotypes and a new concept of persistent bacteremia: a prospective cohort study.
The purpose of this study was to describe and compare the duration of Staphylococcus aureus bacteremia (SAB) according to methicillin resistance and primary foci of infection. We also aimed to newly define persistent SAB considering these results. Non-duplicated episodes of SAB in patients aged ≥15 years from 14 hospitals between January 2009 and February 2018 in Korea were analyzed. The duration of SAB was defined as the number of days from the administration of a susceptible antibiotic after the onset of SAB to the last day of positive blood culture for S. aureus SAB durations were described and compared based on methicillin resistance and the primary foci of infection. Cases in the top quartile for the duration of bacteremia under the respective clinical context were classified as newly defined persistent SAB, and its association with in-hospital mortality was evaluated. A total of 1917 cases were analyzed. The duration of SAB was longer in methicillin-resistant SAB (MRSAB, n=995) compared to methicillin-susceptible SAB (MSSAB, n=922) (days, median [interquartile range], 1 (1-3) in MSSAB vs. 1 (0-5) in MRSAB; P<0.001). Duration of bacteremia was longer in endocarditis, bone and joint, endovascular, and surgical site infections and was shorter in skin and soft tissue infections. Newly defined persistent SAB was independently associated with in-hospital mortality (adjusted odds ratio 1.97, 95% confidence interval 1.54-2.53; P<0.001). Durations of SAB were dependent on methicillin resistance and the primary foci of infection, and persistent SAB considering these contexts was significantly associated with in-hospital mortality.